Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3676 AL 3690

[A female case of phospholipase A2 group VI-associated neurodegeneration with childhood onset and long-term follow-up until 49 years of age]

Mimori M, Kanazawa K, Sato W, Saika R, Yugeta A, Takiyama Y, Takahashi Y.

Rinsho Shinkeigaku. 2026 Apr 22;66(4):235-242. doi: 10.5692/clinicalneurol.cn-002096. Epub 2026 Mar 11.

Neurocircuitry of gait: Brainstem integration of rhythmicity and goal-directed behavior in normal and pathological states

Farhani N, Szturm T, Hobson DE.

Neurosci Biobehav Rev. 2026 Apr;183:106577. doi: 10.1016/j.neubiorev.2026.106577. Epub 2026 Jan 27.

Roles of Microglia in Synaptogenesis, Synaptic Pruning, and Synaptic Plasticity in Physiological Conditions and Central Nervous System Disorders

Xie M, Wang T, Feng J, Ma D, Feng L, Hao Y.

Curr Neuropharmacol. 2026;24(1):2-35. doi: 10.2174/1570159X23666250225091729.

Interactions Between Nutraceuticals and α-Synuclein Conformational States: Molecular Mechanisms and Neuroprotective Implications in Parkinson's Disease

Amenta B, Minervini R, Matrella ML, Cocco T.

Int J Mol Sci. 2026 Jan 28;27(3):1324. doi: 10.3390/ijms27031324.

Targeting α-Synuclein: Current Strategies and Emerging Therapies for Synucleinopathies

Bala VC, Singh MK, Kumar A, Tiwari SK, Gupta AK, Chawla R, Kumar S.

Protein Pept Lett. 2026;33(1):258-274. doi: 10.2174/0109298665429866260217115717.

IKK-β inhibition as a precision therapeutic approach to disrupt the NF-κB neuroinflammatory cascade in Parkinson's disease

Das S, Roy A, Bhattacharya P, Borah A.

Eur J Pharmacol. 2026 Jun 15;1027:178988. doi: 10.1016/j.ejphar.2026.178988. Epub 2026 May 16.

Gene therapy for Parkinson's disease: current landscape, translational challenges, and future directions

Evola V, Parmar MS.

Expert Rev Neurother. 2026 May;26(5):425-442. doi: 10.1080/14737175.2026.2647033. Epub 2026 Apr 2.

Cannabinoids and cognition in Parkinson's disease: Insights from animal models and emerging clinical evidence

Kitchigina VF, Shubina L.

Neuroscience. 2026 May 25;603:37-49. doi: 10.1016/j.neuroscience.2026.03.023. Epub 2026 Mar 19.

Epidemiological burden of Alzheimer's and Parkinson's diseases in East Asia: A comparative review of global burden of disease estimates and national registry data

Fan SP, Liu PC, Wang JZ, Win NN, Lin CH, Lin HH.

J Formos Med Assoc. 2026 Mar 20:S0929-6646(26)00242-1. doi: 10.1016/j.jfma.2026.03.072. Online ahead of print.

No New Relevant Treatment Options for L-DOPA-Induced Dyskinesia from a Clinician's Point of View

Müller T.

Neurol Int. 2026 Mar 20;18(3):59. doi: 10.3390/neurolint18030059.

AI-based mouse behavior analysis in pathology: A focus on movement disorders

Alcacer C, Jercog PE.

Neurosci Biobehav Rev. 2026 Jul;186:106704. doi: 10.1016/j.neubiorev.2026.106704. Epub 2026 Apr 22.

Core themes of high quality, safe inpatient care for people with PD

Killeen E.

Ir J Med Sci. 2026 May 13. doi: 10.1007/s11845-026-04451-7. Online ahead of print.

Cognitive trajectories in Parkinson's disease patients, a review on the impact of subthalamic deep brain stimulation (STN-DBS) and emerging adaptive strategies

Almeida V, Herz DM, Blech J, Hülser M, Oertel J, Martens D, González-Escamilla G, Groppa S.

Transl Psychiatry. 2026 Apr 10;16(1):233. doi: 10.1038/s41398-026-04013-6.

How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review

Ren B, Yan H, Han C, Sun S, Wang D, Xu Y, Xie J.

Neuroscience. 2026 Apr 16;600:141-152. doi: 10.1016/j.neuroscience.2026.02.036. Epub 2026 Feb 21.

[Dementia in the Lewy Body Disease Spectrum]

Nishio Y.

Brain Nerve. 2026 Jan;78(1):5-12. doi: 10.11477/mf.188160960780010005.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias